Skip to main content

Lifestyle Enzymes Gluteneze (Miasca Investments Pty Ltd)

Product Name
Lifestyle Enzymes Gluteneze
ARTG
152882
Date of review outcome
Date of publication
Sep-21
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, if you follow the recommended actions below
What action should consumers take?
This medicine should not be used without consultation with your health practitioner. Be aware that the medicine may not work as expected in relation to relieving symptoms relating to conditions of gluten intolerance and allergy, assisting with the digestion of gluten protein and aiding in the management of sinus ailments, leaky gut, infections, diabetes and autism.
Review scope
Targeted
Information reviewed
Advertising (other), ARTG Record, Labels
Issues related to safety
None
Issues related to efficacy
The label for the medicine and advertising directed exclusively to health practitioners claimed that it may help relieve symptoms of conditions of gluten intolerance and allergy. The advertising also claimed that it may assist the digestion of gluten protein and aid in the management of sinus ailments, leaky gut, infections, diabetes and autism. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with the medicine. The sponsor cancelled the medicine and withdrew it from further supply.

Help us improve the Therapeutic Goods Administration site